Filter
797
Text search:
drug
shortage
Featured
Recommendations
63
New Publications
292
Language
Document type
No document type
535
Studies & Reports
118
Guidelines
68
Strategic & Response Plan
31
Manuals
27
Training Material
7
Situation Updates
7
Infographics
2
Fact sheets
2
Countries / Regions
India
42
Ethiopia
38
Kenya
32
Liberia
30
Uganda
29
Sierra Leone
27
Malawi
27
Western and Central Europe
24
Nigeria
23
Tanzania
22
South Africa
22
Myanmar / Burma
20
Zambia
19
Bangladesh
19
Global
16
Namibia
14
Lesotho
13
Ghana
12
Zimbabwe
12
Nepal
11
Syria
11
Botswana
11
Asia
11
Eastern Europe
11
Africa
10
Cambodia
9
Mozambique
9
Rwanda
8
Latin America and the Carribbean
8
Ukraine
7
South–East Asia Region
7
Burkina Faso
6
Philippines
6
Senegal
5
Haiti
5
South Sudan
5
Guinea
4
Germany
4
Indonesia
4
Venezuela
4
Cameroon
3
Pakistan
3
Thailand
3
Benin
3
North Macedonia
3
East and Southern Africa
3
West and Central Africa
3
Laos
3
Russia
3
Moldova
3
Vietnam
3
Congo, Democratic Republic of
2
Jordan
2
Afghanistan
2
Lebanon
2
Eswatini/ Swaziland
2
Brazil
2
Colombia
2
Yemen
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Palestine
2
Albania
2
Tajikistan
2
USA
1
Turkey
1
China
1
Papua New Guinea
1
Central African Republic
1
Argentina
1
Peru
1
Hungary
1
Bolivia
1
Libya
1
Madagascar
1
Mexico
1
Sri Lanka
1
Chile
1
Poland
1
Italy
1
Bulgaria
1
Estonia
1
Lithuania
1
France
1
Maldives
1
Mauritius
1
United Kingdom
1
Portugal
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
429
Clinical Guidelines
49
Public Health
34
Women & Child Health
25
Key Resources
14
Capacity Building
8
Pharmacy & Technologies
4
Toolboxes
TB
58
Mental Health
54
COVID-19
49
HIV
44
AMR
31
Caregiver
18
Conflict
17
Pharmacy
17
NCDs
16
Ebola
13
Disability
11
NTDs
11
Rapid Response
10
Natural Hazards
9
Planetary Health
9
Global Health Education
7
Refugee
6
Cholera
4
Polio
3
Health Financing Toolbox
3
Specific Hazards
2
Social Ethics
2
Zika
1
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized
...
The world is not on track to end the AIDS pandemic. New infections are rising and AIDS deaths are continuing in too many communities. This report reveals why: inequalities are holding us back. In frank terms, the report calls the world’s attention to the painful reality that dangerous inequalities
...
Uganda hosts approximately 1.1 million refugees making it Africa’s largest refugee hosting country and one of the five largest refugee hosting countries in the world. Most recently, throughout 2016- 2018, Uganda was impacted by three parallel emergencies from South Sudan, the Democratic Republic o
...
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri
...
This new guidance aims to support programme implementers, coordinators and others in humanitarian settings in their actions to counter suicide and self-harm in humanitarian contexts and to save lives.
Trachoma causes more vision loss and blindness than any other infection in the world. This disease is caused by Chlamydia trachomatis bacteria. Other variants or strains of these bacteria can cause a sexually transmitted infection (chlamydia) and disease in lymph nodes.
This is photomicrograph
...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r
...
Access to health workers who are fit for purpose, motivated and protected is a fundamental force of health service delivery and the achievement of universal health coverage and the health and health-related Sustainable Development Goals. Data and knowledge of the distribution, skill mix and future d
...
Female Genital Schistosomiasis (FGS) is a gynaecological disease caused by Schistosoma haematobium, a parasitic worm that is acquired by skin contact with freshwater contaminated by schistosome cerceriae. Communities in which the infection is most endemic have limited access to clean water and healt
...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan
...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
Since the beginning of the Ukraine crisis on 24 February 2022, WHO has supported Government-led efforts and initiatives alongside key partners on the ground. Building on efforts to date, and working alongside Bulgaria’s health authorities to bring added value to existing mechanisms, the WHO Countr
...
The NDMS&IP focuses on mainstreaming disability to promote equitable access to services in the six thematic areas of health, education, livelihoods, empowerment, and social inclusion and cross-cutting issues.
The first part of the NDMS&IP outlines incongruences between national and sectoral policie
...
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to these essential medicines. Enhancing access to controll
...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i
...
The Country Cooperation Strategy is the World Health Organization’s corporate framework developed in response to a country’s needs and priorities. The 2022–2025 CCS is the fourth for WHO in Sierra Leone. It is a medium-term strategic document that defines a broad framework for WHO’s work, at
...
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of
...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm
...
Unpreparedness of health professionals to address non-communicable diseases (NCD) at peripheral health facilities is a critical health system challenge in Mozambique. To address this weakness and decentralize NCD care, training of the primary care workforce is needed. We describe our experience in t
...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (
...
